HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2024-03-14EMA Withdrawn: Sustiva (efavirenz) — Bristol-Myers Squibb Pharma EEIG
Sustiva (efavirenz) has been withdrawn from the EU market.
-
CLINICAL_TRIALS withdrawal · 2023-12-19Clinical Trial Update: Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone [Phase 3]
Phase 3 trial evaluating ritonavir-boosted atazanavir or darunavir with optimized NRTI backbone for second-line HIV-1 treatment has been wit…
-
CLINICAL_TRIALS withdrawal · 2023-04-25Clinical Trial Update: To Investigate the Efficacy and Safety of UB-421 Monotherapy in HIV-1 Infected Adults [Phase 3]
Phase 3 trial investigating UB-421 monotherapy for HIV-1 infection has been withdrawn.
-
EMA withdrawal · 2023-03-21EMA Withdrawn: Nevirapine Teva (nevirapine) — Teva B.V.
EMA withdrew Nevirapine Teva (nevirapine) from the market; HIV infections was the therapeutic area.
-
EMA withdrawal · 2023-01-16EMA Withdrawn: Trogarzo (Ibalizumab) — Theratechnologies Europe Limited
The EMA has withdrawn Trogarzo (ibalizumab) from Theratechnologies Europe Limited for treatment of HIV infections.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2022-04-12Clinical Trial Update: Dolutegravir-Lamivudine as Dual Therapy in naïve HIV-Infected Patients With Documented M184V Mutation:A Pilot Study [Phase 4]
A Phase 4 pilot trial evaluating dolutegravir-lamivudine dual therapy in ART-naïve HIV-1 patients with M184V mutation has been withdrawn.
-
EMA withdrawal · 2022-01-21EMA Withdrawn: Atripla (efavirenz;emtricitabine;tenofovir disoproxil fumarate) — Gilead Sciences Ireland UC
EMA has withdrawn Atripla (efavirenz; emtricitabine; tenofovir disoproxil fumarate) from the market; therapeutic area: HIV infections.
-
CLINICAL_TRIALS withdrawal · 2021-11-04Clinical Trial Update: The Safety and Effectiveness of Methylprednisolone in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Children With AIDS [Phase 3]
Phase 3 trial assessing methylprednisolone for Pneumocystis pneumonia in children with AIDS was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-09-20Clinical Trial Update: A Study of the Pharmacokinetic and Pharmacodynamic Interactions Between Bictegravir, Tenofovir Alafenamide and Rifapentine in Healthy Adult Subjects [Phase 4]
A Phase 4 pharmacokinetic/pharmacodynamic study evaluating interactions between bictegravir, tenofovir alafenamide, and rifapentine in healt…
-
CLINICAL_TRIALS withdrawal · 2021-06-10Clinical Trial Update: Pharmacokinetics of Single-dose Dolutegravir in HIV-seronegative Subjects With Severe Hepatic Impairment Compared to Matched Controls. [Phase 4]
A Phase 4 pharmacokinetic trial evaluating single-dose dolutegravir in HIV-seronegative subjects with severe hepatic impairment compared to …
-
CLINICAL_TRIALS withdrawal · 2020-11-06Clinical Trial Update: Pharmacokinetics of Maraviroc and Boosted Atazanavir Dual Regimen in Stable HIV-infected Patients [Phase 3]
A Phase 3 pharmacokinetics study of a maraviroc and boosted atazanavir dual regimen in stable HIV-infected patients was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2020-08-18Clinical Trial Update: Chloroquine Outpatient Treatment Evaluation for HIV-Covid-19 [Phase 3]
A Phase 3 clinical trial evaluating chloroquine for outpatient treatment of HIV and COVID-19 was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-12-16Clinical Trial Update: Impact of Sirolimus and Maraviroc on CCR5 Expression and the HIV-1 Reservoir in HIV-infected Kidney Transplant Recipients [Phase 4]
Phase 4 trial evaluating sirolimus and maraviroc on CCR5 expression and HIV-1 reservoir in HIV-infected kidney transplant recipients has bee…
-
CLINICAL_TRIALS withdrawal · 2019-06-13Clinical Trial Update: A Study of the Safety and Effectiveness of Simeprevir and Sofosbuvir for Patients With HIV and Hepatitis C [Phase 4]
Phase 4 trial of simeprevir and sofosbuvir for HIV/Hepatitis C was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-12-26Clinical Trial Update: The Use of Nutropin Depot in HIV-infected Adult Males [Phase 2, Phase 3]
Clinical trial update for Nutropin Depot in HIV-infected adult males shows the study has been withdrawn after Phase 2/3.
-
CLINICAL_TRIALS withdrawal · 2018-07-18Clinical Trial Update: HIV - Monotherapy in Switzerland (MOST-ch) [Phase 4]
A Phase 4 clinical trial evaluating HIV monotherapy in Switzerland (MOST-ch) has been terminated.
-
CLINICAL_TRIALS withdrawal · 2018-05-30Clinical Trial Update: Impact of Screening Patients With HIV for Kidney Disease
The clinical trial evaluating screening HIV patients for kidney disease has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-04-17Clinical Trial Update: Improving Fibrosis Outcomes With Metformin [Phase 2]
A Phase 2 trial evaluating metformin for fibrosis outcomes has been withdrawn from the study.
-
CLINICAL_TRIALS withdrawal · 2017-12-04Clinical Trial Update: Predictors of Time to Viremia With an Analytic Treatment Interruption
The HIV study NCT03033017 evaluating predictors of time to viremia during analytic treatment interruption has been withdrawn.
-
EMA withdrawal · 2017-04-27EMA Withdrawn: Dutrebis (lamivudine;raltegravir potassium) — Merck Sharp Dohme Limited
EMA withdrew Dutrebis (lamivudine and raltegravir potassium) for HIV infections, decision dated 26 March 2015.
-
CLINICAL_TRIALS withdrawal · 2017-04-25Clinical Trial Update: Victim Impact Modules for Jail Inmates [NA]
The clinical trial evaluating victim impact modules for jail inmates has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-04-04Clinical Trial Update: A RCT of Prednisone as Adjunctive Therapy for Hospitalized Patients With Pulmonary TB and HIV Co-infection [Phase 3]
A Phase 3 randomized trial of prednisone as adjunctive therapy for hospitalized patients with pulmonary tuberculosis and HIV co-infection wa…
-
CLINICAL_TRIALS withdrawal · 2017-03-06Clinical Trial Update: Treatment Plan to Decrease Drug Exposure in HIV Infected Adolescents [NA]
The clinical trial NCT00067574 evaluating a treatment plan to decrease drug exposure in HIV-infected adolescents has been withdrawn. No furt…
-
CLINICAL_TRIALS withdrawal · 2017-03-03Clinical Trial Update: PRO 140 for Human Immunodeficiency Virus [Phase 2]
A Phase 2 trial of PRO 140 (leronlimab) for HIV sponsored by Drexel University has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-02-28Clinical Trial Update: Trial of Probiotics to Lower Microbial Translocation and Immune Activation in HIV-Infected Adolescents [NA]
A clinical trial investigating probiotics to lower microbial translocation and immune activation in HIV-infected adolescents has been withdr…